Effect of rosiglitazone on circulating malondialdehyde (MDA) level in diabetes based on a systematic review and meta-analysis of eight clinical trials
Ziba Majidi, Shaghayegh Hosseinkhani, Nasrin Amiri-Dashatan, Solaleh Emamgholipour, Sara Tutunchi, Javad Hashemi, Fatemeh Ghorbani, Mehdi Koushki
DOI: 10.1136/jim-2020-001588 Published 22 December 2020
Ziba Majidi
1
Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)
Shaghayegh Hosseinkhani
1
Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)
Nasrin Amiri-Dashatan
2
Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran (the Islamic Republic of)
Solaleh Emamgholipour
1
Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)
Sara Tutunchi
3
Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran (the Islamic Republic of)
Javad Hashemi
4
Department of Clinical Biochemistry, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnord, Iran (the Islamic Republic of)
Fatemeh Ghorbani
1
Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)
Mehdi Koushki
5
Department of Clinical Biochemistry, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran (the Islamic Republic of)
No eLetters have been published for this article.
Effect of rosiglitazone on circulating malondialdehyde (MDA) level in diabetes based on a systematic review and meta-analysis of eight clinical trials
Ziba Majidi, Shaghayegh Hosseinkhani, Nasrin Amiri-Dashatan, Solaleh Emamgholipour, Sara Tutunchi, Javad Hashemi, Fatemeh Ghorbani, Mehdi Koushki
Journal of Investigative Medicine Dec 2020, jim-2020-001588; DOI: 10.1136/jim-2020-001588
Effect of rosiglitazone on circulating malondialdehyde (MDA) level in diabetes based on a systematic review and meta-analysis of eight clinical trials
Ziba Majidi, Shaghayegh Hosseinkhani, Nasrin Amiri-Dashatan, Solaleh Emamgholipour, Sara Tutunchi, Javad Hashemi, Fatemeh Ghorbani, Mehdi Koushki
Journal of Investigative Medicine Dec 2020, jim-2020-001588; DOI: 10.1136/jim-2020-001588
Effect of rosiglitazone on circulating malondialdehyde (MDA) level in diabetes based on a systematic review and meta-analysis of eight clinical trials
Ziba Majidi, Shaghayegh Hosseinkhani, Nasrin Amiri-Dashatan, Solaleh Emamgholipour, Sara Tutunchi, Javad Hashemi, Fatemeh Ghorbani, Mehdi Koushki
Journal of Investigative Medicine Dec 2020, jim-2020-001588; DOI: 10.1136/jim-2020-001588